“Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology”
The purpose of this research is to study the effects of nasal oxytocin administration on maternal behaviors that may be influenced by cocaine use during pregnancy. 32 mothers with prenatal use of cocaine during the current pregnancy will be studied at 3-6 months postpartum, when they will complete 3 study visits, a 2-week double-blind trial of twice daily nasal spray (oxytocin or placebo) and 4 telephone interviews. All information collected is confidential.
Drug - Syntocinon treatment
24 IU twice daily (A single dose will be delivered consisting of 6 intranasal insufflations (3 in each nostril) which is equivalent to a total of 24 international units (IU) of oxytocin twice daily).
Placebo nasal spray vials will contain the same ingredients in the nasal preparation, but without oxytocin.
Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology